Infectious Diseases News and Research

RSS

K. Hovnanian Children's Hospital announces opening of new specialty care center

K. Hovnanian Children's Hospital at Jersey Shore University Medical Center is proud to announce the grand opening of K. Hovnanian Children's Hospital Specialty Care Center, a consolidated outpatient pediatric center serving as the new home of Meridian Pediatric Associates. The center provides pediatric specialty care services in a comfortable and friendly environment, and is an important first step of the hospital's new pediatric expansion project.

20 Apr 2012

JSUMC launches Soiree at the Shore event

This year the Jersey Shore University Medical Center Foundation is proud to announce the launch of Soiree at the Shore, a new and exciting event taking the calendar date of the successful Runway on the River.

20 Apr 2012

Babies rarely became ill from MRSA infections: Study

The need to swab the noses of pregnant women and newborns for the presence of MRSA (methicillin-resistant Staphylococcus aureus) may be unfounded, according to a Vanderbilt study now available online and published in the May issue of Pediatrics.

20 Apr 2012

CSIS report examines future of global health agenda

In a new report examining the future of the global health agenda, published by the Center for Strategic & International Studies (CSIS) on Tuesday, J. Stephen Morrison, director of the Center on Global Health Policy and a senior vice president at CSIS, writes, "The naught decade (2000–2009) saw remarkable, explosive growth, concentrated in low- and lower-middle-income countries, in dollars delivered to infectious diseases -- HIV/ AIDS, tuberculosis, along with maternal and child health, and health systems."

19 Apr 2012

Bristol-Myers Squibb, Janssen expand TMC435, BMS-986094 clinical collaboration agreement

Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that its development partner, Janssen R&D Ireland has broadened its clinical collaboration agreement with Bristol-Myers Squibb Company.

19 Apr 2012

Strengthening collective voice, influence of biomedical researchers in global health field

In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, guest blogger Jessica Taaffe, founder of Scientists for Global Health (SciGlo) and a postdoctoral fellow researching severe malaria immunopathogenesis at the National Institute of Allergy and Infectious Diseases, "discusses the importance of the biomedical community's contributions to improving health worldwide,"

18 Apr 2012

Addiction to opioids has higher risk of death than alcohol or other drugs

People with an opioid addiction had the highest risk of death when compared with rates for alcohol and other drugs, according to a new study by the Centre for Addiction and Mental Health (CAMH).

18 Apr 2012

Large childhood immunization campaign begins in Haiti, with support from U.S., other international partners

Haiti, the U.S. and other international partners on Monday launched "a nationwide vaccination campaign in the Caribbean country that seeks to curb or prevent infectious diseases, health officials said," the Associated Press/Fox News reports.

18 Apr 2012

Gates Foundation, Brazilian health ministry form alliance to expand Grand Challenges in Global Health initiative

The Bill & Melinda Gates Foundation on Monday announced it has formed an alliance "with the Brazilian Ministry of Health in the latest expansion of the foundation's Grand Challenges in Global Health initiative," the Puget Sound Business Journal reports.

18 Apr 2012

Allied Healthcare announces Coridon license to vector technology

Allied Healthcare Group (ASX: AHZ) has announced an update on the progress of Coridon, its investment company founded by Professor Ian Frazer and working on developing the next generation of vaccines. Included in these activities, Cordon has entered into a license agreement with Nature Technology Corporation (NTC) and has contracted VGXI Inc. in the US for production of clinical material for the Phase I study scheduled to begin later this year.

17 Apr 2012

ACS, CDC partner to improve surgical patient safety

A joint, strategic partnership to improve surgical patient safety at the national level was announced today by leaders of the American College of Surgeons (ACS) and the Centers for Disease Control and Prevention.

17 Apr 2012

Genetically modified mosquitoes offer hope of malaria eradication amid growing drug resistance

"In recent weeks, the emergence on the Thai-Myanmar border of malaria strains resistant to artemisinin, a plant-derived drug, have led to pessimistic headlines and reminders of the setback caused by resistance to the drug chloroquine, which began in the 1950s," columnist and author Matt Ridley writes in the Wall Street Journal's "Mind & Matter," noting, "April 25 is World Malaria Day, designed to draw attention to the planet's biggest infectious killer."

17 Apr 2012

MDI to advance Detect-Ready MRSA Panel with $1.9M Series B recapitalization financing

Molecular Detection Inc., a company developing Detect-Ready® tests designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has completed a $1.9 million Series B recapitalization financing.

16 Apr 2012

Scientists identify which T. gondii strains are linked with severe illness in U.S. infants

Scientists have identified which strains of the Toxoplasma gondii parasite, the cause of toxoplasmosis, are most strongly associated with premature births and severe birth defects in the United States.

16 Apr 2012

Next five years important for S. Africa to show it can effectively respond to HIV, TB

South Africa's recently released "National Strategic Plan on HIV, Sexually Transmitted Infections (STIs) and Tuberculosis (TB) 2012-2016" "marked an important milestone" in the nation's fight against infectious diseases, a Lancet editorial states.

16 Apr 2012

HPA urges routine vaccination after surge of whooping cough cases

The Health Protection Agency (HPA) said there have been 665 confirmed cases already this year, compared with 1,040 in the whole of 2011. Cases have been reported across all regions in England with some areas reporting clusters in schools, universities and healthcare settings.

15 Apr 2012

FDA urges restriction in injudicious use of antibiotics in livestock

The Food and Drug Administration (FDA) has urged drug companies Wednesday to help limit the use of antibiotics in farm animals. The researchers say that this decades-old practice has contributed to a surge in dangerous, drug-resistant bacteria.

12 Apr 2012

DNDi, AstraZeneca enter collaboration on drug-compound screening for NTDs

AstraZeneca and the Drugs for Neglected Diseases initiative (DNDi) today announce an agreement to collaborate on drug-compound screening for leishmaniasis, Chagas disease, and sleeping sickness, three neglected tropical diseases (NTDs) which together affect nearly 10 million people worldwide.

12 Apr 2012

Discontinuing antibiotic used to prevent opportunistic infections among HIV patients could increase risk of malaria, diarrhea

"Abruptly discontinuing co-trimoxazole -- an antibiotic used to prevent opportunistic infections in HIV-positive people -- can lead to a higher incidence of malaria and diarrhea compared with patients who keep on taking the drug," according to a study conducted by the CDC in eastern Uganda and published by the Oxford Journal of Clinical Infectious Diseases in March, PlusNews reports.

12 Apr 2012

Quest Diagnostics receives FDA clearance for Simplexa C. difficile Universal Direct test

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its Simplexa C. difficile Universal Direct Test on the 3M Integrated Cycler.

From Quest Diagnostics 12 Apr 2012

Infectious Diseases News and Research

K. Hovnanian Children's Hospital announces opening of new specialty care center

JSUMC launches Soiree at the Shore event

Babies rarely became ill from MRSA infections: Study

CSIS report examines future of global health agenda

Bristol-Myers Squibb, Janssen expand TMC435, BMS-986094 clinical collaboration agreement

Strengthening collective voice, influence of biomedical researchers in global health field

Addiction to opioids has higher risk of death than alcohol or other drugs

Large childhood immunization campaign begins in Haiti, with support from U.S., other international partners

Gates Foundation, Brazilian health ministry form alliance to expand Grand Challenges in Global Health initiative

Allied Healthcare announces Coridon license to vector technology

ACS, CDC partner to improve surgical patient safety

Genetically modified mosquitoes offer hope of malaria eradication amid growing drug resistance

MDI to advance Detect-Ready MRSA Panel with $1.9M Series B recapitalization financing

Scientists identify which T. gondii strains are linked with severe illness in U.S. infants

Next five years important for S. Africa to show it can effectively respond to HIV, TB

HPA urges routine vaccination after surge of whooping cough cases

FDA urges restriction in injudicious use of antibiotics in livestock

DNDi, AstraZeneca enter collaboration on drug-compound screening for NTDs

Discontinuing antibiotic used to prevent opportunistic infections among HIV patients could increase risk of malaria, diarrhea

Quest Diagnostics receives FDA clearance for Simplexa C. difficile Universal Direct test

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News